Follow
Vasileios Konstantakos
Vasileios Konstantakos
PhD(c) @ University of Leuven, VIB-KU Leuven Center for Brain & Disease Research
Verified email at kuleuven.be - Homepage
Title
Cited by
Cited by
Year
CRISPR–Cas9 gRNA efficiency prediction: an overview of predictive tools and the role of deep learning
V Konstantakos, A Nentidis, A Krithara, G Paliouras
Nucleic Acids Research 50 (7), 3616-3637, 2022
962022
A Multi-Label Classifier for Predicting the Most Appropriate Instrumental Method for the Analysis of Contaminants of Emerging Concern
N Alygizakis, V Konstantakos, G Bouziotopoulos, E Kormentzas, ...
Metabolites 12 (3), 199, 2022
52022
CRISPRedict: a CRISPR-Cas9 web tool for interpretable efficiency predictions
V Konstantakos, A Nentidis, A Krithara, G Paliouras
Nucleic Acids Research 50 (W1), W191-W198, 2022
42022
Omentin Is Independently Associated with Stroke Severity and Ipsilateral Carotid Artery Stenosis in Patients with Acute Cerebral Ischemia
M Chondrogianni, V Lambadiari, AH Katsanos, MI Stefanou, ...
Journal of Clinical Medicine 10 (24), 5797, 2021
42021
Delayed recurrent enhancing white matter lesions complicating coiling of intracranial aneurysm
E Bakola, AH Katsanos, L Palaiodimou, A Theodorou, MI Stefanou, ...
European Journal of Neurology 28 (7), 2388-2391, 2021
32021
CRISPRedict: The case for simple and interpretable efficiency prediction for CRISPR-Cas9 gene editing
V Konstantakos, A Nentidis, A Krithara, G Paliouras
bioRxiv, 2022.04. 07.486362, 2022
12022
Modeling the off-target effects of CRISPR-Cas9 experiments for the treatment of Duchenne Muscular Dystrophy
E Koutsoni, V Konstantakos, A Nentidis, A Krithara, G Paliouras
Proceedings of the 12th Hellenic Conference on Artificial Intelligence, 1-7, 2022
2022
The system can't perform the operation now. Try again later.
Articles 1–7